Back

The AdaptResponse trial- ongoing trial.

23 May 2016 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30 Cardiac resynchronisation therapy HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Mrs Sandra Jacobs

University of Antwerp, Antwerp (Belgium)

22 More presentations in this session

Presentation thumbnail
Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors
Presentation thumbnail
Long-term effects and sustainability of collaborative disease management in systolic heart failure - the extended interdisciplinary network heart failure study
Professor C. Angermann (Wurzburg, DE)
Presentation thumbnail
An implantable pressure sensor for long-term wireless monitoring of cardiac function -first study in man
Doctor J. Baranowski (Linkoping, SE)
Presentation thumbnail
Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time in EMPA-REG OUTCOME
Doctor D. Fitchett (Toronto, CA)
Presentation thumbnail
Long-term safety and efficacy of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalaemia: interim analysis of ZS-005, an open-label phase 3 study
Professor S. Anker (Berlin, DE)
Slides

Access the full session

Session thumbnail
Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30

The Event

Event poster

HEART FAILURE 2016

23 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
AdaptResponse: A randomized study of synchronized LV pacing
17 April 2023
thumbnail
Congress Presentation
Adaptive design with bayesian informed interim decisions: application to a randomized trial of mechanical circulatory support.
27 August 2021
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025
thumbnail
Webinar
The EAPCI Journal Club - RESHAPE-HF2: percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
5 November 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources